After myocardial injury, cardiomyocyte loss cannot be corrected by using currently available
clinical treatments. In recent years, considerable effort has been made to develop cell-based …

The heart, the first organ to develop in the embryo, undergoes complex morphogenesis that
when defective results in congenital heart disease (CHD). With current therapies, more than …

The number of adults with congenital heart disease (ACHD) has progressively increased in
recent years to surpass that of children. This population growth has produced a new …

Predicting heart disease is regarded as one of the most difficult challenges in the health-
care profession. To predict cardiac disease, researchers employed a variety of algorithms …

Congenital heart disease (CHD), the most common form of developmental abnormality in
humans, remains a leading cause of morbidity and mortality in neonates. Genetic defects …

A remarkable number of deaths in foetal cardiac disorders have been reduced as a result of
significant gains in survival. Arrhythmias are most common issue that patients encounter …

Background Almost 90% of patients with congenital heart disease (CHD) now reach
adulthood. How do they evaluate the care they received? Methods Adults with CHD (ACHD) …

Post-myocardial infarction heart failure (post-MI HF) is one of the leading global causes of
death, and current prevention and treatment methods still cannot avoid the increasing …

Aims To develop and validate a clinically useful risk prediction tool for patients with adult
congenital heart disease (ACHD). Methods and results A risk model was developed in a …

Background We describe calendar time trends of patients with simple congenital heart
disease. Methods and Results Using the nationwide Danish registries, we identified …